Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Press Releases.
Press releases published on July 31, 2025

Acquisition of The Lens Project: Call for Expressions of Interest
Cambia seeks expressions of interest from qualified and aligned organisations or individuals for the acquisition of The Lens. CANBERRA, ACT, AUSTRALIA, July 31, 2025 /EINPresswire.com/ -- Cambia, a non-profit social enterprise based in Australia, is …

Orchestra BioMed Announces Proposed Public Offering
NEW HOPE, Pa., July 31, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, announced …

Ligand and Medtronic Commit $70 Million in Strategic Capital to Orchestra BioMed
• Ligand to invest $35 million in exchange for a tiered royalty on future sales of Orchestra’s AVIM therapy and Virtue SAB and an additional $5 million in an equity private placement • Medtronic to invest $10 million in an equity private placement and an …

Ascendis Pharma to Report Second Quarter 2025 Financial Results and Provide Business Update on August 7, 2025
COPENHAGEN, Denmark, July 31, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced it will report second quarter 2025 financial results and provide a business update on Thursday, August 7, 2025, after the close of the U.S. financial …

Asure Announces Second Quarter 2025 Results
Second Quarter 2025 Total Revenues Increased 7% to $30.1 million Recurring Revenues Grew 6% from Prior Year AUSTIN, Texas, July 31, 2025 (GLOBE NEWSWIRE) -- Asure Software, Inc. (“we”, “us”, “our”, “Asure” or the “Company”) (Nasdaq: ASUR), a leading …

scPharmaceuticals to Announce Second Quarter 2025 Financial Results After the Market Close on August 7, 2025
BURLINGTON, Mass., July 31, 2025 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company committed to revolutionizing cardiorenal healthcare through patient-centric innovations, today announced that scPharmaceuticals management …

Corvus Pharmaceuticals to Provide Business Update and Second Quarter 2025 Financial Results on August 7, 2025
SOUTH SAN FRANCISCO, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that the company will host a conference call and webcast on August 7, 2025 at 4:30 pm ET …

Ruanyun Edai Technology Announces Financial Results for Fiscal Year 2025
NANCHANG, China, July 31, 2025 (GLOBE NEWSWIRE) -- Ruanyun Edai Technology Inc. (“Ruanyun” or the “Company”) (NASDAQ: RYET), a leading AI-powered education technology company in China, today announced its financial results for the fiscal year ended March …

Bilan semestriel du contrat de liquidité de la société Inventiva conclu avec Kepler Cheuvreux
Daix (France), New York (New York, Etats-Unis), le 31 juillet 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (la "Société"), société biopharmaceutique spécialisée dans le développement clinique de petites molécules administrées par voie orale pour le …

Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux
Daix (France), New York (New York, United States), July 31, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the …

Nephros Schedules Second Quarter 2025 Financial Results Conference Call
SOUTH ORANGE, N.J., July 31, 2025 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its second-quarter financial …

ZenaDrone de ZenaTech inicia la actualización de su membresía en AUVSI, lo que permite el liderazgo en la política de drones y fortalece la colaboración con el sector de defensa y el gobierno de EE.UU.
VANCOUVER, British Columbia, July 31, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), un proveedor de soluciones de tecnología empresarial especializado en drones con IA (Inteligencia Artificial), Dron como un …

Incora 实现 AS13100 合规,成为首个加入 AESQ 的全球分销商成员
得克萨斯州沃思堡, Aug. 01, 2025 (GLOBE NEWSWIRE) -- 全球领先的航空航天和国防行业综合供应链解决方案提供商 Incora,今日宣布达成两项重要里程碑,进一步彰显其对质量和持续改进的承诺。 经过为期三年的严格流程,Incora 已 100% 符合 AS13100,这是针对航空发动机供应商的标准化质量管理体系要求。 这一成就使 Incora 跻身于少数能够达到行业在流程控制、风险管理和产品完整性方面最严格标准的公司之列。 与此同时,Incora 已被接纳为航空发动机供应商质量 …

Incora décroche l’agrément AS13100 et devient le premier distributeur mondial référencé de l’AESQ
FORT WORTH, Texas, 31 juill. 2025 (GLOBE NEWSWIRE) -- Incora, un leader mondial des solutions logistiques intégrées au service des secteurs de l’aérospatiale et de la défense, annonce ce jour avoir franchi les deux étapes majeures de son développement qui …

Incora 獲得 AS13100 合規認證,加入 AESQ 成為首個全球分銷商成員
沃思堡,德州, Aug. 01, 2025 (GLOBE NEWSWIRE) -- 航天與國防界整合供應鏈解決方案的全球領先供應商 Incora 今日宣布達成兩大關鍵里程碑,鞏固對卓越質素及不斷改進的承擔。 Incora 歷經三年的嚴謹審核,如今全面符合 AS13100 標準,達到航天引擎供應商的標準化質素管理系統要求。 行內對程序控制、風險管理及產品完整性具有極嚴格要求,達到標準的企業為數不多,達成里程碑後的 Incora 正能躋身其中。 與此同時,Incora 獲准加入航天引擎供應商質素 (AESQ) …

Optimove Insights Holiday Shopping Survey Finds 48% of Consumers Plan to Spend More in 2025, Despite Concerns Over Tariffs and Inflation
New York, July 31, 2025 (GLOBE NEWSWIRE) -- According to the Optimove Insights 2025 Consumer Holiday Shopping Report, forty-eight percent (48%) of consumers plan to increase their holiday shopping budgets, signaling strong seasonal intent. Yet the optimism …

SONY Joins the AR Alliance to Advance the Future of Augmented Reality Wearable Devices
PISCATAWAY, N.J., July 31, 2025 (GLOBE NEWSWIRE) -- The AR Alliance announces that SONY has joined the alliance as an associate member. The AR Alliance provides a supportive and neutral environment for organizations of all sizes to take an active role in …

PolTREG and U.S. Subsidiary Immuthera Secure Positive FDA Opinion, Paving the Way for a Registrational Pre-Symptomatic Type 1 Diabetes Trial
PolTREG and U.S. Subsidiary Immuthera Secure Positive FDA Opinion, Paving the Way for a Registrational Pre-Symptomatic Type 1 Diabetes Trial FDA agreed that PolTREG’s clinical data in Stage 3 Type 1 Diabetes (T1D) appears sufficient to support the Prospect …

Telnyx Supercharges European Voice AI with Paris GPU Edge, Breaking 200ms Latency Barrier
AUSTIN, Texas, July 31, 2025 (GLOBE NEWSWIRE) -- Telnyx, the vertically integrated operator powering low-latency voice AI agents, today lit up a new GPU-accelerated Voice-AI Point-of-Presence (PoP) in Paris, France. By embedding its inference stack …

The AR Alliance Welcomes Magic Leap, Tekscend Photomask, and UC San Diego as New Members
PISCATAWAY, N.J., July 31, 2025 (GLOBE NEWSWIRE) -- The AR Alliance a program of the ISTO federation that is dedicated to advancing open and interoperable augmented reality (AR) ecosystem standards, proudly announces the addition of four influential …